<DOC>
	<DOCNO>NCT00382642</DOCNO>
	<brief_summary>The purpose study learn whether ondansetron safe effective treatment alcohol dependence . We also want learn whether study drug ondansetron combine Cognitive Behavioral Therapy assist researcher determine whether certain gene responsible determine person benefit benefit use ondansetron alcohol dependence .</brief_summary>
	<brief_title>Pharmacological Treatment Alcoholism</brief_title>
	<detailed_description>This 13 week outpatient clinical trial . Participants either receive ondansetron placebo behavioral therapy . There 1 , 2 , 3 month post-study follow visit.Screening study initially do telephone take 15-20 minute . If participant eligible initial screen , invite come thorough house screen take 5 6 hour . The screen include physical exam , review medical , alcohol drug history blood collection . If participant find eligible house screen , enrol 13 week outpatient clinical trial .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Males female give write informed consent . Ages 18 year , must weigh least 40 Kg 140 Kg Good physical health determine complete physical examination , EKG within normal limit , laboratory screening test within acceptable parameter . Audit score equal 8 Current DSMIV diagnosis alcohol dependence Currently drink equal 14 alcohol units/week woman equal 21 alcohol units/week men last 30 day . Provide evidence stable residence last month prior enrollment study , plan move next three month . The pregnancy test female intake must negative . Additionally , woman childbearing potential must use acceptable form contraception . These include : oral contraceptive , hormonal ( levonorgestrel ) surgical implant , barrier plus spermicide . Literate English able read , understand , complete rating scale questionnaire accurately , follow instruction , make use behavioral treatment . Answer advertisement newspaper/radio/television , express wish stop drinking . Willingness participate behavioral treatment alcoholism . Subjects legally mandate participate alcohol treatment program . Any current axis I DSM IV psychiatric disorder alcohol nicotine dependence Elevation liver enzyme ( SGOT ) , serum glutamic pyruvic transaminase ( SGPT ) , blood urea nitrogen ( BUN ) , lactate dehydrogenase ( LDH ) great four time normal range , clinically significant elevate direct bilirubin deem principal investigator . Severe alcohol withdrawal symptom physicians opinion require inpatient treatment . Serious medical comorbidity require medical intervention close supervision , condition , interfere receipt ondansetron . Severe lifethreatening adverse reaction ondansetron similar medication either past clinical trial . Female patient pregnant , lactating , adhere acceptable form contraception time study . Received inpatient outpatient treatment alcohol dependence within last 30 day ( support group AA exclusionary ) . Compelled participate alcohol treatment program maintain liberty . Members household . Treated medication potential effect alcohol consumption relate behavior , mood . These include : opiate antagonist ( e.g . naltrexone ) , glutamate antagonist ( e.g. , acamprosate ) , serotonin reuptake inhibitor ( e.g . fluoxetine ) , serotonin antagonist ( e.g . ritanserin buspirone ) , antidepressant ( e.g . tricyclic antidepressant monoamine oxidase inhibitor ) , dopamine antagonist ( e.g . haloperidol ) , calcium channel antagonist ( e.g . isradipine ) , compound action similar disulfiram ( antabuse ) nicotine . Before doubleblind randomization , urine must free opiate , cocaine , amphetamine , barbiturate , benzodiazepine , prescription nonprescription drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>alcoholism , alcohol disorder , drinking , alcohol</keyword>
</DOC>